Farmacia Hospitalaria y Farmacogenómica

Escudero-Vilaplana, V; Romero-Medrano, L; Villanueva-Bueno, C; de Diago, MR; Yanez-Montesdeoca, A; Collado-Borrell, R; Campana-Montes, JJ; Marzal-Alfaro, B; Revuelta-Herrero, JL; Calles, A; Galera, M; Alvarez, R; Herranz, A; Sanjurjo, M; Artes-Rodriguez, A.

Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App

Frontiers in Oncology. 2022; 12: [doi:10.3389/fonc.2022.880430]

Vicente-Valor, J; Escudero-Vilaplana, V; Collado-Borrell, R; Lopez-Lopez, C; Villanueva-Bueno, C; Revuelta-Herrero, JL; Ruiz-Briones, P; Somoza-Fernandez, B; Herranz, A; Sanjurjo, M.

Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022; 28(5): 1259-1263 Nº de citas: 5 [doi:10.1177/10781552221074621]

Garcia-Sanchez, S; Collado-Borrell, R; Gonzalez-Haba, E; Revuelta-Herrero, JL; Escudero-Vilaplana, V; Marzal-Alfaro, MB; Sanchez-Fresneda, MN; Mur-Mur, A; Herranz, A; Martin, M; Sanjurjo, M.

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Frontiers in Oncology. 2022; 12: Nº de citas: 3 [doi:10.3389/fonc.2022.889575]

Olmedo, M; Kestler, M; Valerio, M; Padilla, B; Rodríguez González C; Chamarro E; Machado, M; Alvarez-Uria, A; Alcala, L; Muñoz P; Bouza, E.

Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(3): 279-283 Nº de citas: 7 [doi:10.37201/req/120.2021]

Escudero-Vilaplana, V; Bernal, E; Casado, G; Collado-Borrell, R; Diez-Fernandez, R; Roman, ABF; Folguera, C; Gonzalez-Cortijo, L; Herrero-Fernandez, M; Marquina, G; Nieto, CM; Rodriguez, MA; Rubio, AR; Sanmartin-Fenollera, P; Castillo, MJV; Comellas, M; Guerra, EM.

Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer

Frontiers in Oncology. 2022; 12: Nº de citas: 4 [doi:10.3389/fonc.2022.885910]

Villanueva-Bueno, C; Collado-Borrell, R; Revuelta-Herrero, JL; Fernandez-Roman, AB; Casado-Abad, G; Escudero-Vilaplana, V.

Implementation of a methodology to assess patient reported outcomes in lung cancer patients: The PeOpLe (Patient-reported Outcomes in Lung cancer) study protocol

FARMACIA HOSPITALARIA. 2022; 46(4): 265-269 Nº de citas: 1 [doi:10.7399/fh.11835]

Collado-Borrell, R; Escudero-Vilaplana, V; Narrillos-Moraza, A; Villanueva-Bueno, C; Herranz-Alonso, A; Sanjurjo-Saez, M.

Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes

FARMACIA HOSPITALARIA. 2022; 46(3): 173-181 Nº de citas: 4 [doi:10.7399/fh.11830]

Moreno-Martinez, E; de la Serna-Torroba, J; Escudero-Vilaplana, V; Hernandez-Rivas, JA; Sanchez-Cuervos, M; Sanchez-Hernandez, R.

Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain

FARMACIA HOSPITALARIA. 2022; 46(3): 121-132 [doi:10.7399/fh.11829]

Martinez-Barrio, J; Lopez, JAM; Galindo, M; Ais, A; Sanchez, NM; Cano, L.

Importance of family planning in patients with immune-mediated inflammatory diseases: A multidisciplinary approach

Reumatologia Clinica. 2022; 18(4): 200-206

Garcia-Sanchez, S; Somoza-Fernadez, B; de Lorenzo-Pinto, A; Ortega-Navarro, C; Herranz-Alonso, A; Sanjurjo, M.

Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis

JMIR mHealth and uHealth. 2022; 10(4): Nº de citas: 7 [doi:10.2196/29985]

Diaz-Navarro, M; Hafian, R; Manzano, I; Perez-Granda, MJ; Cercenado, E; Pascual, C; Rodriguez, C; Munoz, P; Guembe, M.

A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

Infectious Diseases and Therapy. 2022; 11(2): 743-755 Nº de citas: 4 [doi:10.1007/s40121-021-00579-4]

Hoyo-Munoz, A; Collado-Borrell, R; Escudero-Vilaplana, V; Bastos-Oreiro, M; Herranz-Alonso, A; Sanjurjo-Saez, M.

Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2022; 47(4): 548-551 Nº de citas: 3 [doi:10.1111/jcpt.13513]

Amor-Garcia, MA; Rodriguez-Gonzalez, CG; Chamorro-de-Vega, E; Herranz-Alonso, A; Sanjurjo-Saez, M.

Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid

ANNALS OF PHARMACOTHERAPY. 2022; 56(4): 401-411 Nº de citas: 7 [doi:10.1177/10600280211038504]

Butragueno-Laiseca, L; Martin, GM; Cortes, RG; Galan, CR; de Marigorta, ZMDM; Anton, JG; Nunez, AR; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Cid, JLH.

Multicenter randomized clinical trial comparing dexamethasone versus placebo in preventing upper airway obstruction after extubation in critically ill children

Scientific Reports. 2022; 12(1): Nº de citas: 6 [doi:10.1038/s41598-022-08178-0]

Romero-Jimenez, R; Escudero-Vilaplana, V; Chamorro-de-Vega, E; Ais-Larisgoitia, A; Matilla, MEL; Herranz-Alonso, A; Sanjurjo, M.

The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

JOURNAL OF MEDICAL INTERNET RESEARCH. 2022; 24(3): Nº de citas: 4 [doi:10.2196/31016]

Tejerina, F; Catalan, P; Rodriguez-Grande, C; Adan, J; Rodriguez-Gonzalez, C; Munoz, P; Aldamiz, T; Diez, C; Perez, L; Fanciulli, C; de Viedma, DG; Gregorio Maranon Microbiol ID COVI.

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

BMC INFECTIOUS DISEASES. 2022; 22(1): Nº de citas: 82 [doi:10.1186/s12879-022-07153-4]

García-Moreno FJ; Escobar-Castellanos M; Marañón R; Rivas-García A; Manrique-Rodríguez S; Mora-Capín A; Fernández-Llamazares CM.

Adecuacy of pediatric antimicrobial prescribing in the Emergency Department at discharge.

Anales De Pediatria. 2022; 96(3): 179-189 [doi:10.1016/j.anpede.2020.11.015]

Garcia-Moreno, FJ; Escobar-Castellanos, M; Maranon, R; Rivas-Garcia, A; Manrique-Rodriguez, S; Mora-Capin, A; Fernandez-Llamazares, CM.

Adecuacy of pediatric antimicrobial prescribing in the Emergency Department at discharge

ANALES DE PEDIATRIA. 2022; 96(3): 179-189 Nº de citas: 5 [doi:10.1016/j.anpedi.2020.11.019]